Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer
The DOI matches its Crossref record; 298 of the 300 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After compiling data from numerous independent reports, mutations in the “RB pathway” were soon proposed to be a hallmark of cancer (19, 38).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [38]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Harris, N., Jaffe, E., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., De Wolf- Peeters, C., Falini, B., & Gatter, K. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,327
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
Kallioniemi, A., Kallioniemi, O.-P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., & Pinkel, D. (1992) · Science · doi:10.1126/science.1359641 · Cited by 3,297
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,535
Vokes, E. E., Weichselbaum, R. R., Lippman, S. M., & Hong, W. K. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280306 · Cited by 2,211
Research works printed but not linked: 134
- Adnane, 1989, Oncogene, 4, 1389
- Akiyama, 1994, Cancer Res., 54, 377
- Ali, 1989, Oncogene, 4, 89
- Athan, 1991, Am. I. Pathol., 138, 591
- Bartkova, 1995, Cancer Res., 55, 949
- Bartkova, 1995, Oncogene, 10, 775
- Bates, 1994, Oncogene, 9, 1633
- Beltinger, 1995, Cancer Res., 55, 2053
- Berenson, 1990, Oncogene, 5, 1343
- Berenson, 1989, Oncogene, 4, 1111
- Bhatia, 1995, Cancer Res., 55, 1431
- Boggild, 1994, J. Clin. Endocrinol. Metab., 78, 387
- Boring, 1993, CA Cancer J. Clin., 43, 7
- Brenner, 1995, Cancer Res., 55, 2892
- Buckley, 1993, Oncogene, 8, 2127
- Bullrich, 1995, Cancer Res., 55, 1199
- Cairns, 1995, Cancer Res., 55, 224
- Cheng, 1994, Cancer Res., 54, 5547
- Cordon-Cardo, 1994, Cancer Res., 54, 794
- Cowan, 1993, Cancer Res., 53, 5542
- de Boer, 1993, Cancer Res., 53, 4148
- de Boer, 1995, Oncogene, 10, 1833
- Dreyling, 1995, Cancer Res., 55, 984
- Duro, 1995, Oncogene, 11, 21
- Fantl, 1993, Cancer Surveys, 18, 77
- Faust, 1992, Cancer Res., 52, 2460
- Forus, 1993, Cell Growth Differ., 4, 1065
- Gaffey, 1993, Mod. Pathol., 6, 654
- Giani, 1994, Cancer Res., 54, 6338
- Gillett, 1994, Cancer Res., 54, 1812
- Gillett, C., Smith, P., Gregory, W., Richards, M., Millis, R., Peters, G., and Barnes, D. (1996). Int. J. Cancer, in press.
- Goodrich, 1993, Biochim. Biophys. Acta, 1155, 43
- Han, 1995, Oncogene, 10, 953
- Hanna, 1993, Oncogene, 8, 1661
- Hatada, 1988, Oncogene, 3, 537
- Hayashi, 1994, Int. J. Hematol., 59, 281
- He, 1994, Cancer Res., 54, 5804
- Ince, 1988, Leukemia, 2, 343
- Jares, 1994, Cancer Res., 54, 4813
- Jen, 1994, Cancer Res., 54, 6353
- Jiang, 1992, Cancer Res., 52, 2980
- Jiang, 1993, Oncogene, 8, 3447
- Jin, 1993, Cancer Res., 53, 2140
- Kawamata, 1995, Cancer Res., 55, 2266
- Keyomarsi, 1994, Cancer Res., 54, 380
- Khatib, 1993, Cancer Res., 53, 5535
- Kitagawa, 1991, Cancer Res., 51, 1504
- Koduru, 1989, Oncogene, 4, 929
- Korsmeyer, 1992, Annu. Rev. Immunol., 10, 785, 10.1146/annurev.iy.10.040192.004033 · doi:10.1146/annurev.iy.10.040192.004033 · Paper page
- Lammie, 1991, Cancer Cells, 3, 413
- Lammie, 1991, Oncogene, 6, 439
- Lammie, 1992, Oncogene, 7, 2381
- Leach, 1993, Cancer Res., 53, 1986
- Lebwohl, 1994, Oncogene, 9, 1925
- Li, 1994, Cancer Res., 54, 6078
- Li, 1995, Oncogene, 11, 597
- Li, 1995, Oncogene, 10, 599
- Lidereau, 1988, Oncogene Res., 2, 285
- Liscia, 1989, Oncogene, 4, 1219
- Liu, 1995, Oncogene, 10, 1061
- Lo, 1995, Cancer Res., 55, 2039
- Louie, 1987, Am. J. Hum. Genet. (Suppl.), 41, 31
- Lucas, 1994, Int. J. Oncol., 5, 469
- Lukas, 1994, Oncogene, 9, 2159
- Meeker, 1991, Leukemia, 5, 733
- Meltzer, 1991, Cell Growth Differ, 2, 495
- Meyers, 1990, Cancer Res., 50, 5911
- Michalides, 1995, Cancer Res., 55, 975
- Mitra, 1994, Cancer Res., 54, 637
- Mori, 1994, Cancer Res., 54, 3396
- Motokura, 1993, Biochim. Biophys. Acta, 1155, 63
- Moulton, 1995, Am. J. Pathol., 146, 613
- Newman, 1993, Blood, 82, 1239, 10.1182/blood.V82.4.1239.1239 · doi:10.1182/blood.v82.4.1239.1239
- Nguyen, 1988, Oncogene, 3, 703
- Nishida, 1994, Cancer Res., 54, 3107
- Ohta, 1994, Cancer Res., 54, 5269
- Okamoto, 1995, Cancer Res., 55, 1448
- Otsuki, 1995, Cancer Res., 55, 1436
- Otterson, 1994, Oncogene, 9, 3375
- Palmero, 1993, Oncogene, 8, 1049
- Parise, 1994, Int. J. Oncol., 5, 309
- Peeper, 1994, Biochim. Biophys. Acta, 1198, 215
- Peters, 1990, Cell Growth Differ., 1, 503
- Peters, 1991, Sem. Virol., 2, 319
- Pietenpol, 1995, Cancer Res., 55, 1206
- Ponce-Castañeda, 1995, Cancer Res., 55, 1211
- Proctor, 1991, Oncogene, 6, 789
- Rabbitts, 1988, Oncogene, 3, 99
- Raffeld, 1991, Blood, 78, 259, 10.1182/blood.V78.2.259.bloodjournal782259 · doi:10.1182/blood.v78.2.259.bloodjournal782259 · Paper page
- Rasheed, 1994, Cancer Res., 54, 1324
- Reifenberger, 1994, Cancer Res., 54, 4299
- Resnitzky, 1994, Mol. Cell. Biol., 14, 1669
- Roberts, 1989, Cancer Res., 49, 5407
- Rogler, 1991, Curr. Topics Microbiol. Irnmunol., 168, 103
- Rosenberg, 1991, Oncogene, 6, 449
- Rosenberg, 1993, Oncogene, 8, 519
- Schmidt, 1994, Cancer Res., 54, 6321
- Schultz, 1995, Cancer Res., 55, 2150
- Schuuring, 1993, Mol. Cell. Biol., 13, 2891
- Schuuring, 1992, Oncogene, 7, 355
- Schuuring, 1992, Cancer Res., 52, 5229
- Seto, 1992, Oncogene, 7, 1401
- Shapiro, 1995, Cancer Res., 55, 505
- Smith, 1992, Cancer Res., 52, 3746
- Somers, 1990, Oncogene, 5, 915
- Speicher, 1995, Cancer Res., 55, 1010
- Sun, 1995, Oncogene, 10, 785
- Sun, 1995, Cancer Epidem. Biomark. Prev., 4, 261
- Szepetowski, 1992, Oncogene, 7, 751
- Szepetowski, 1992, Oncogene, 7, 2513
- Tam, 1994, Oncogene, 9, 2663
- Theillet, 1990, Oncogene, 5, 147
- Theillet, 1989, Oncogene, 4, 915
- Tsuda, 1989, Cancer Res., 49, 3104
- Tsuda, 1989, Jpn. J. Clin. Oncol., 19, 26
- Tsuda, 1989, Cancer Res., 49, 5505
- Varley, 1988, Oncogene, 3, 87
- Wagata, 1991, Cancer Res., 51, 2113
- Walker, 1995, Cancer Res., 55, 20
- Wang, 1992, Oncogene, 7, 1653
- Washimi, 1995, Cancer Res., 55, 514
- Weisenburger, 1991, Leukemia, 1, 26
- Williams, 1992, Cancer Res., 52, 5541s
- Withers, 1991, Mol. Cell. Biol., 11, 4846
- Xiao, 1995, Oncogene, 11, 511
- Xu, 1994, Cancer Res., 54, 5262
- Yang, 1994, Am. J. Pathol., 145, 86
- Yoshida, 1994, Oncol. Rep., 1, 493
- Yoshida, 1995, Cancer Res., 55, 2756
- Zhang, 1994, Cancer Res., 54, 5050
- Zhou, 1989, Oncogene, 4, 105
- Zhou, 1988, Oncogene, 2, 279
- Zhou, 1995, Oncogene, 11, 571
- Zhou, 1994, Oncogene, 9, 3737
Cited by
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130
A Genome-Wide Transcriptional Analysis of the Mitotic Cell Cycle
Cho, R. J., Campbell, M. J., Winzeler, E. A., Steinmetz, L., Conway, A., Wodicka, L., Wolfsberg, T. G., Gabrielian, A. E., Landsman, D., Lockhart, D. J., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80114-8 · Cited by 2,046
“Cells exhibited over 95% synchrony throughout(Hunter and Pines, 1994; Wang et al., 1994; Sherr and the time course, as determined by bud size and nuclearRoberts, 1995; Wölfel et al., 1995; Hall and Peters, 1996). position (Figure 1).”
BackgroundThe cell cycle: a review of regulation, deregulation and therapeutic targets in cancer
Vermeulen, K., Van Bockstaele, D. R., & Berneman, Z. N. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.2003.00266.x · Cited by 1,773
“Approximately 90% of human cancers have abnormalities in some component of the pRb pathway (Hall & Peters 1996).”
BackgroundInfluential
Metadata
- Authors
- Hall, M., & Peters, G. G.
- ORCID
- Marcia Hall
- Venue
- Advances in cancer research
- Publisher
- Elsevier
- Published
- 1996
- Volume
- 68
- Pages
- 67-108
- ISSN
- 0065-230X (ISSN-L)
- OpenAlex
- W1569698611
- Cited by
- 752
- References
- 300
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 7 · 2023: 12 · 2022: 11 · 2021: 20 · 2020: 12 · 2019: 19 · 2018: 15 · 2017: 9 · 2016: 18 · 2015: 21 · 2014: 24 · 2013: 16 · 2012: 19
- FWCI
- 56.53
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Advances in cancer research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- cyclins, cyclin-dependent kinases, cyclin-dependent kinase inhibitors, human cancer, cyclin D1, CCND1, CDK4, p16, retinoblastoma protein, cell cycle regulation, tumor suppressor, cell proliferation, glioma, sarcoma
- MeSH terms
- Cell Cycle, Enzyme Inhibitors, Humans, Mutation, Neoplasms, Translocation, Genetic, Oncogene Proteins, Cyclins, Cyclin-Dependent Kinases, Cyclin D1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer. https://app.cochat.ai/papers/10.1016/s0065-230x(08)60352-8
- The paper
- Hall, M., & Peters, G. G. (1996). Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer. Advances in cancer research. https://doi.org/10.1016/s0065-230x(08)60352-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.